Foresite Capital Management II as of Dec. 31, 2017
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 11 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 41.0 | $117M | 3.1M | 37.82 | |
| Aerie Pharmaceuticals | 34.9 | $100M | 1.7M | 59.75 | |
| Epizyme | 6.8 | $20M | 1.6M | 12.55 | |
| Insmed (INSM) | 5.7 | $16M | 519k | 31.18 | |
| Alder Biopharmaceuticals | 4.2 | $12M | 1.0M | 11.45 | |
| Acceleron Pharma | 3.6 | $10M | 245k | 42.44 | |
| Denali Therapeutics (DNLI) | 1.4 | $3.9M | 250k | 15.64 | |
| Juno Therapeutics | 1.4 | $3.9M | 85k | 45.71 | |
| Uniqure Nv (QURE) | 0.8 | $2.1M | 109k | 19.59 | |
| Loxo Oncology | 0.3 | $1.0M | 12k | 84.20 | |
| Alder Biopharmaceuticals Inc call | 0.0 | $40k | 24k | 1.67 |
